It's such a "new" drug that it's not on many of the lists comparing/explaining the various 2nd and 3rd Tier Diabetes Medications

It was first approved for sale in the US in November of 2022 and then everywhere else exactly a year later in 2023 - so has only been on the International Market for a "few months" - it's going take time to be widely listed

I am presently prescribed Mounjaro for type 2 diabetes not weight loss.

Mounjaro is a once a week injection designed for weight loss.